Biglycan anticorps (N-Term) (Cy3)
Aperçu rapide pour Biglycan anticorps (N-Term) (Cy3) (ABIN7972752)
Antigène
Voir toutes Biglycan (BGN) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Fonction
- Anti-Biglycan/BGN Antibody Cy3 Conjugated
-
Réactivité croisée (Details)
- No cross-reactivity with other proteins
-
Homologie
- identical to the related mouse,rat sequences.
-
Purification
- Immunogen affinity purified.
-
Immunogène
- A synthetic peptide corresponding to a sequence at the N-terminus of human Biglycan/BGN, identical to the related mouse and rat sequences.
-
Isotype
- IgG
-
-
-
-
Indications d'application
- Flow Cytometry, 1-3 μg/1x106 cells
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Each vial contains 50 % glycerol, 0.9 % NaCl, 0.2 % Na2HPO4, 0.02 % Sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C
-
Stockage commentaire
- At -20°C for one year from date of receipt. Avoid repeated freezing and thawing. Protect from light.
-
Date de péremption
- 12 months
-
-
- Biglycan (BGN)
-
Autre désignation
- BGN
-
Sujet
-
Background: This gene encodes a member of the small leucine-rich proteoglycan (SLRP) family of proteins. The encoded preproprotein is proteolytically processed to generate the mature protein, which plays a role in bone growth, muscle development and regeneration, and collagen fibril assembly in multiple tissues. This protein may also regulate inflammation and innate immunity. Additionally, the encoded protein may contribute to atherosclerosis and aortic valve stenosis in human patients. This gene and the related gene decorin are thought to be the result of a gene duplication.
Gene Full Name: biglycan
-
ID gène
- 633
-
UniProt
- P21810
-
Pathways
- Glycosaminoglycan Metabolic Process
Antigène
-